Search

Gary Dean Glick

from Comfort, TX
Age ~67
Get Report
Also known as:
Gary D Glick, Gary D Click, Glick Gary
Phone and address:
901 Fm 473, Comfort, TX 78013
(830) 324-6117
Related to:
Shantae Gary, 34Barrett Glick, 26Melissa Mcclung, 54Daniel Glick, 59
Connected to:
Alice W Glick, 65Angela M Glick, 50Anthony Glick, 43Ashlynn E Glick, 28Bonnie L Glick, 58Caleb J Glick, 40Carolyn F Glick, 41Celeste M Glick, 66Charles S Glick, 76Chris R Glick, 40

Gary Glick Phones & Addresses

  • 901 Fm 473, Comfort, TX 78013 (830) 324-6117
  • Hudson, MA
  • Portland, OR
  • Breckenridge, TX
  • 2607 Caravan Cir, San Antonio, TX 78258 (210) 881-9831
  • Dripping Springs, TX
  • Kendalia, TX
  • Orland Park, IL
  • Plano, TX
  • Chicago, IL

Professional Records

Medicine Doctors

Gary Glick Photo 1

Gary L. Glick

View page
Specialties:
General Surgery, Vascular Surgery
Work:
Gary L Glick MD
4308 Alton Rd STE 410, Miami Beach, FL 33140
(305) 672-6100 (phone), (305) 532-7444 (fax)
Education:
Medical School
Emory University School of Medicine
Graduated: 1988
Procedures:
Appendectomy
Breast Biopsy
Endoscopic Retrograde Cholangiopancreatography (ERCP)
Gallbladder Removal
Hallux Valgus Repair
Hemorrhoid Procedures
Hernia Repair
Laparoscopic Gallbladder Removal
Sigmoidoscopy
Small Bowel Resection
Thyroid Gland Removal
Tracheostomy
Abdominal Aortic Aneurysm
Breast Reduction
Endarterectomy
Laparoscopic Appendectomy
Lower Leg Amputation
Mastectomy
Peripheral Vascular Bypass
Proctosigmoidoscopy
Thromboendarterectomy of the Peripheral Arteries
Upper Gastrointestinal Endoscopy
Varicose Vein Procedures
Conditions:
Cholelethiasis or Cholecystitis
Hemorrhoids
Inguinal Hernia
Malignant Neoplasm of Female Breast
Varicose Veins
Languages:
English
Spanish
Description:
Dr. Glick graduated from the Emory University School of Medicine in 1988. He works in Miami Beach, FL and specializes in General Surgery and Vascular Surgery. Dr. Glick is affiliated with Aventura Hospital Medical Center, Jackson North Medical Center and North Shore Medical Center.

Business Records

Name / Title
Company / Classification
Phones & Addresses
Gary Glick
Manager
Fish
Other Individual & Family Svcs
1335 SE Hawthorne Blvd, Portland, OR 97214
(503) 233-5533
Gary Glick
Manager
Edward Jones 01312
Security Brokers and Dealers · Investment Advice
1513 W Walker St, Breckenridge, TX 76424
(254) 559-3326
Gary Glick
Vice Presi, Vice President
BEAR-IT SPORTS LLC
901 Fm 473, Comfort, TX 78013
12758 Cimarron Path, San Antonio, TX 78249
Gary Glick
Provenir LLC
Business Consulting, Nec, Nsk · Medical Doctor's Office
16607 Blanco Rd, San Antonio, TX 78232
12770 Cmrron Path, San Antonio, TX 78249
12758 Cmrron Path, San Antonio, TX 78249
Gary D. Glick
Manager
C.O.F.F.E.E. Lovers, LLC
Gary Glick
Manager
ARTISAN WOODWORKS LLC
2607 Caravan Cir, San Antonio, TX 78258
Gary D. Glick
Synergy Sports, Inc
Gary D. Glick
Legal Links, LLC

Publications

Wikipedia

Gary Glick

View page

Gary Galen Glick (May 14, 1930 February 11, 2015) was a professional American football safety who played seven seasons in the National Football League.

ISBN #

1

Us Patents

Methods Of Treating Or Selecting A Treatment For A Subject Resistant To Tnf Inhibitor Using A Nlrp3 Antagonist

View page
US Patent:
20220339169, Oct 27, 2022
Filed:
Jul 2, 2019
Appl. No.:
17/252630
Inventors:
- Basel, CH
Shomir GHOSH - Brookline MA, US
Gary GLICK - Ann Arbor MI, US
Jason KATZ - Newton MA, US
William R. ROUSH - Boston MA, US
Hans Martin SEIDEL - Concord MA, US
Shankar VENKATRAMAN - Lansdale PA, US
David Guenther WINKLER - Arlington MA, US
International Classification:
A61K 31/64
C07K 16/24
A61K 45/06
C12Q 1/6827
C12N 15/113
Abstract:
Provided herein are methods of treating a subject that include administering a therapeutically effective amount of an NLPR3 antagonist or a pharmaceutically acceptable salt, solvate, or co-crystal thereof to a subject identified as having a cell that has an elevated level of NLRP3 inflammasome activity and/or expression as compared to a reference level. Provided herein are methods of treating a subject, methods of selecting a treatment for a subject, methods of selecting a subject for treatment, and methods of selecting a subject for participation in a clinical study that include the administration of a therapeutically effective amount of an NLRP3 antagonist. Also provided are methods of treating a subject having resistance to an anti-TNFα agent and methods of determining the efficacy of treatment with an anti-TNFα agent. Also provided are methods of treating a subject with a combination of an NLRP3 antagonist and an anti-TNFα agent.

Nlrp Modulators

View page
US Patent:
20220267276, Aug 25, 2022
Filed:
Jul 2, 2019
Appl. No.:
17/252623
Inventors:
- Basel, CH
Shomir GHOSH - Brookline MA, US
Gary GLICK - Ann Arbor MI, US
Jason KATZ - Newton MA, US
William R. ROUSH - Boston MA, US
Hans Martin SEIDEL - Concord MA, US
Shankar VENKATRAMAN - Lansdale PA, US
David Guenther WINKLER - Arlington MA, US
International Classification:
C07D 221/16
C07D 277/36
C07D 417/12
C07D 213/75
C07C 335/42
A61K 45/06
Abstract:
In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt thereof, are featured: or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula A can be as defined anywhere herein, useful to treat connected to the modulation of NRLP3.

Compounds And Compositions For Treating Conditions Associated With Nlrp Activity

View page
US Patent:
20230079631, Mar 16, 2023
Filed:
May 11, 2022
Appl. No.:
17/662863
Inventors:
- Basel, CH
Shomir GHOSH - Brookline MA, US
Gary GLICK - Ann Arbor MI, US
Jason KATZ - Newton MA, US
William ROUSH - Boston MA, US
Hans Martin SEIDEL - Concord MA, US
Shankar VENKATRAMAN - Lansdale PA, US
David Guenther WINKLER - Arlington MA, US
International Classification:
C07D 265/30
A61P 1/00
A61P 11/00
A61P 19/08
A61P 35/00
C07C 381/10
C07D 209/26
C07D 211/78
C07D 215/06
C07D 231/12
C07D 239/26
C07D 239/36
C07D 261/08
C07D 263/46
C07D 277/36
C07D 317/50
C07D 333/34
C07D 401/12
C07D 409/12
C07D 417/12
Abstract:
In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt thereof, are featured:or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula A can be as defined anywhere herein.

Compounds And Compositions For Treating Conditions Associated With Nlrp Activity

View page
US Patent:
20230062815, Mar 2, 2023
Filed:
Oct 7, 2021
Appl. No.:
17/496375
Inventors:
- Basel, CH
Shomir GHOSH - Brookline MA, US
Gary GLICK - Ann Arbor MI, US
Jason KATZ - Newton MA, US
William ROUSH - Boston MA, US
Hans Martin SEIDEL - Concord MA, US
Shankar VENKATRAMAN - Lansdale PA, US
David Guenther WINKLER - Arlington MA, US
International Classification:
C07D 277/36
C07D 215/36
C07D 231/18
C07D 239/26
C07D 263/46
C07D 307/64
C07D 307/79
C07D 317/62
C07D 333/34
C07D 487/04
C07C 307/06
Abstract:
In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt thereof, are featured:

The Compounds And Compositions For Treating Conditions Associated With Nlrp Activity

View page
US Patent:
20230059136, Feb 23, 2023
Filed:
Nov 14, 2019
Appl. No.:
17/293787
Inventors:
- Basel, CH
Shomir GHOSH - Brookline MA, US
Gary GLICK - Ann Arbor MI, US
Jason KATZ - Newton MA, US
William ROUSH - Boston MA, US
Hans Martin SEIDEL - Concord MA, US
Shankar VENKATRAMAN - Lansdale PA, US
David Guenther WINKLER - Arlington MA, US
International Classification:
C07D 277/80
C07D 333/34
C07C 311/57
C07D 231/12
C07D 317/60
C07D 307/36
C07D 417/12
Abstract:
In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt thereof, are featured: Formula AA or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula A can be as defined anywhere herein.

Compounds And Compositions For Treating Conditions Associated With Nlrp Activity

View page
US Patent:
20230051589, Feb 16, 2023
Filed:
Nov 14, 2019
Appl. No.:
17/293781
Inventors:
- Basel, CH
Shomir GHOSH - Brookline MA, US
Gary GLICK - Ann Arbor MI, US
Jason KATZ - Newton MA, US
William ROUSH - Boston MA, US
Hans Martin SEIDEL - Concord MA, US
Shankar VENKATRAMAN - Lansdale PA, US
David Guenther WINKLER - Arlington MA, US
International Classification:
A61K 31/426
A61K 45/06
A61K 31/64
C07D 307/64
C07D 277/36
A61K 31/381
C07D 333/34
C07D 409/12
A61K 31/4436
A61K 31/18
C07C 381/10
C07D 231/18
A61K 31/415
A61K 31/36
A61K 31/4406
A61K 31/47
C07D 317/62
C07D 213/71
C07D 215/36
C07D 487/04
C07D 405/12
A61K 31/4188
A61K 31/397
C07D 205/04
C07D 295/096
A61K 31/5375
C07D 207/10
A61K 31/40
A61K 31/4015
C07D 207/12
C07D 333/72
A61K 31/451
C07D 211/24
C07D 495/04
A61K 31/4365
A61P 1/00
A61P 37/06
Abstract:
In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt thereof, are featured: Formula AA or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula A can be as defined anywhere herein.

Compounds And Compositions For Treating Conditions Associated With Nlrp Activity

View page
US Patent:
20200087270, Mar 19, 2020
Filed:
Sep 16, 2019
Appl. No.:
16/572528
Inventors:
- Cambridge MA, US
Shomir GHOSH - Brookline MA, US
Gary GLICK - Ann Arbor MI, US
Jason KATZ - Newton MA, US
William ROUSH - Jupiter FL, US
Hans Martin SEIDEL - Concord MA, US
Shankar VENKATRAMAN - Lansdale PA, US
David Guenther WINKLER - Arlington MA, US
International Classification:
C07D 277/36
C07D 307/64
C07D 333/34
Abstract:
In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt thereof, are featured:

Amazon

Camp Shriver: a model for including children with intellectual disabilities in summer camp.(Report): An article from: Camping Magazine

View page

This digital document is an article from Camping Magazine, published by Thomson Gale on July 1, 2007. The length of the article is 3437 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker i...
Author

Gary N. Siperstein, Gary C. Glick, Coreen M. Harada, Jennifer Norins Bardon, Robin C. Parker

Binding

Digital

Pages

12

Publisher

Thomson Gale

ISBN #

2

Control profile
Gary Dean Glick from Comfort, TX, age ~67 Get Report